[6-K] NatWest Group plc Current Report (Foreign Issuer)

Rhea-AI Filing Summary

NatWest Group plc reports it purchased ordinary shares in the Company on 02 October 2025 from Merrill Lynch International (BofA). The filing includes aggregated trade information and refers investors to a full breakdown of individual trades in an attached PDF at the provided URL. The aggregated section in this text shows numeric entries that appear to represent quantities and prices but are not presented in a clear, standard format in the body of this report. The filing is signed by Mark Stevens and cites compliance with the Market Abuse Regulation disclosure requirement.

Positive

• Company executed share repurchases, indicating active use of its buyback programme
• Regulatory compliance noted: the filing references Article 5(1)(b) and provides an attachment with a trade breakdown
• Authorized signature present (Mark Stevens), completing required attestations

Negative

• In-line numeric data is unclear or misformatted, preventing verification of total shares or aggregate consideration from the body text
• Key quantitative details (clear total shares repurchased and total cash spent) are not presented directly in this text and require the linked PDF

Insights

Financial Analyst

Routine buyback disclosure; confirms active share repurchase but lacks clear totals in-line.

The filing discloses share repurchases executed via BofA on 02 October 2025 and points to an attached breakdown for transaction-level detail. For investors, the material element is the company conducting repurchases under its programme, which can support EPS and capital return objectives. However, the inline aggregation is not clearly formatted here, so assessment of scale or daily totals requires the attached PDF. This disclosure meets regulatory reporting but provides limited on-page quantitative clarity.

Corporate Governance Expert

Compliance-focused disclosure; references required trade breakdown but in-text data is unclear.

The report references Article 5(1)(b) of the Market Abuse Regulation and supplies an external link to a full trade breakdown, indicating procedural compliance for buyback transparency. The signature by an authorized officer is present. The filing does not include a clear, complete in-line summary of total shares repurchased or aggregate spend, so stakeholders must consult the linked document to verify governance and capital allocation implications.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

October, 2025

Commission File Number 001-10306

NatWest Group plc

250 Bishopsgate,

London, EC2M 4AA

United Kingdom

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

The following information was issued as Company announcements in London, England and is furnished pursuant to General Instruction B to the General Instructions to Form 6-K:

NatWest Group plc

02 October 2025

Transaction in Own Shares

NatWest Group plc (the "Company") announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ("Ordinary Shares") from Merrill Lynch International ("BofA").

Aggregated information:

Date of purchase	Number of Ordinary Shares purchased	Highest price paid: (GBp)	Lowest price paid: (GBp)	Volume  weighted average price paid per share (GBp)	Venue
02-Oct-25	218,778	533.40	527.40	529.04	LSE
02-Oct-25	51,217	533.40	527.40	529.14	BATE
* Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share
Such purchases form part of the Company's existing share buyback programme and were effected pursuant to the instructions issued by the Company to BofA on 25 July 2025, as announced on 28 July 2025.
The Company intends to cancel the repurchased Ordinary Shares.
Following the settlement of the above transactions, the Company will hold 230,977,670 Ordinary Shares in treasury and have 8,040,896,156 Ordinary Shares in issue (excluding treasury shares).
Further information:
Investor Relations
+ 44 (0)207 672 1758
Media Relations
+44 (0)131 523 4205
Legal Entity Identifier: 2138005O9XJIJN4JPN90

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by BofA on behalf of the Company as part of the buyback programme is detailed in the attached:

http://www.rns-pdf.londonstockexchange.com/rns/9018B_1-2025-10-2.pdf

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			NatWest Group plc (Registrant)
Date:	02 October 2025			By:	/s/ Mark Stevens
				Name:	Mark Stevens
				Title:	Assistant Secretary

FAQ

What did NatWest Group (NWG) disclose in this 6-K?

The company disclosed that it purchased ordinary shares on 02 October 2025 from Merrill Lynch International (BofA) and provided a link to a detailed breakdown of individual trades.

Does the filing state how many shares NatWest repurchased?

The body text shows numeric entries that appear related to quantities and prices but is not clearly formatted; the filing directs readers to the attached PDF for the full breakdown.

Where can I find the full transaction-level details for the buyback?

The filing provides a link to the detailed trade breakdown: http://www.rns-pdf.londonstockexchange.com/rns/9018B_1-2025-10-2.pdf.

Who signed the report for NatWest Group?

The report is signed by Mark Stevens as the authorized representative.

Does this 6-K explain why the repurchase was made?

No. The filing reports the repurchase activity and references regulatory disclosure requirements but does not provide commentary on strategic rationale.